Cargando…

SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe

Detalles Bibliográficos
Autores principales:	Vavougios, George D., Zarogiannis, Sotirios G., Hadjigeorgiou, Georgios, Krogfelt, Karen A., Gourgoulianis, Konstantinos I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087889/ https://www.ncbi.nlm.nih.gov/pubmed/35545022 http://dx.doi.org/10.1016/j.stemcr.2022.04.011

Ejemplares similares

Response to: SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe
por: Krasemann, Susanne, et al.
Publicado: (2022)

Type I interferon: friend or foe?
por: Trinchieri, Giorgio
Publicado: (2010)

Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
por: Papaioannou, Andriana I, et al.
Publicado: (2006)

Obstructive Sleep Apnea Syndrome Comorbidity Phenotypes in Primary Health Care Patients in Northern Greece
por: Ntenta, Panagiota K., et al.
Publicado: (2022)

Risk Assessment for Self Reported Obstructive Sleep Apnea and Excessive Daytime Sleepiness in a Greek Nursing Staff Population
por: Alexandropoulou, Alexia, et al.
Publicado: (2019)

Cross Sectional Study of the Community Self-Reported Risk of Obstructive Sleep Apnoea (OSA) and Awareness in Thessaly, Greece
por: Kassas, Petros, et al.
Publicado: (2022)

Type I interferons in tuberculosis: Foe and occasionally friend
por: Moreira-Teixeira, Lúcia, et al.
Publicado: (2018)

Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status
por: Rouka, Erasmia, et al.
Publicado: (2017)

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
por: Vasileiadis, Georgios K., et al.
Publicado: (2018)

Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer’s disease
por: Vavougios, George D., et al.
Publicado: (2021)

Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
por: Zanoni, Ivan
Publicado: (2021)

Interferon Gamma in African Trypanosome Infections: Friends or Foes?
por: Wu, Hui, et al.
Publicado: (2017)

Evaluation of Sirtuin 1 Levels in Peripheral Blood Mononuclear Cells of Patients With Idiopathic Pulmonary Fibrosis
por: Deskata, Konstantina, et al.
Publicado: (2022)

Systematic review and meta‐analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions
por: Fafliora, Eleftheria, et al.
Publicado: (2016)

In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma
por: Rouka, Erasmia, et al.
Publicado: (2019)

Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe?
por: Gole, Sarin, et al.
Publicado: (2022)

Neuronal Mitophagy: Friend or Foe?
por: Doxaki, Christina, et al.
Publicado: (2021)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Breast cancer cell lines: friend or foe?
por: Burdall, Sarah E, et al.
Publicado: (2003)

Friend and Foe
Publicado: (1890)

Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
por: Murira, Armstrong, et al.
Publicado: (2016)

COVID-19 Phenotypes and Comorbidity: A Data-Driven, Pattern Recognition Approach Using National Representative Data from the United States
por: Vavougios, George D., et al.
Publicado: (2022)

The emerging epigenetics of PARK7 and its implication in neurodegenerative disease
por: Vavougios, George D., et al.
Publicado: (2018)

Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?
por: Yu, Cai-Guo, et al.
Publicado: (2016)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

IL-33/ST2 Axis in Organ Fibrosis
por: Kotsiou, Ourania S., et al.
Publicado: (2018)

Friend or foe: RIG- I like receptors and diseases
por: Song, Jie, et al.
Publicado: (2022)

Are the emerging SARS-COV-2 mutations friend or foe?
por: Erol, Adnan
Publicado: (2021)

The Effects of Stevia Consumption on Gut Bacteria: Friend or Foe?
por: Kasti, Arezina N., et al.
Publicado: (2022)

Carbon Nanotubes and Other Engineered Nanoparticles Induced Pathophysiology on Mesothelial Cells and Mesothelial Membranes
por: Sinis, Sotirios I., et al.
Publicado: (2018)

Media and breastfeeding: Friend or foe?
por: Brown, Jane D, et al.
Publicado: (2008)

Friend to the brain, foe to the spine
por: Maxmen, Amy
Publicado: (2008)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eggrbi5218d730g6gcumggidvu